Press Releases
US LABS in the News
3/20/1998 12:00:00 AM - US Labs announces $15 million financing
Date: March 20, 1998
Irvine, California - U.S. Labs, an integrated pathology services company focused on pathology practice management and anatomic pathology laboratory operations, today announced it received an equity capital commitment of $15 million from three leading private venture firms: Accel Partners of Palo Alto, Patricof & Co. Ventures, Inc., of Palo Alto, and Highland Capital of Boston.
"Our aim is to help pathologists increase their earnings by keeping them competitive and in control," said U.S. Labs Chairman, Michael R. Danzi, "We are uniquely positioned to streamline delivery of pathology services and bring greater value to our affiliated practices through capital infusion, managed care contracting, professional business management, centralized laboratory, administrative, and information services, and an aggressive sales and marketing effort aimed at enhancing the incomes of pathologists who partner with us."
"The strength of our financial backers - their solid reputations in the healthcare industry, their experience with medical practice management, and their extensive industry contacts - place U.S. Labs in a powerful position with respect to our ability to attract pathology practice affiliations, establish strategic business alliances, and capture hospital and managed care contracts," said Danzi, "We view ourselves as the leader in consolidating anatomic pathology services on the West Coast. Our equity partners will help us to fortify that position." U.S. Labs, formerly named AccuPath, is an integrated anatomic pathology services company specializing in anatomic pathology laboratory operations and pathology practice management. The company was founded in 1996 and is headquartered in Irvine, California, where it operates a national anatomic pathology reference laboratory.
For additional information about US LABS, contact Dennis E. Walsh, VP Sales and Marketing at 949-450-0145. E-mail: dwalsh@uslabs.net.
